1. Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, University of Cologne, Cologne, Germany,
2. Hôpital Avicenne, Assistance Publique–Hôpitaux de Paris (AP-HP), Service d'Hématologie Biologique, Bobigny, France,
3. Institute for Medical Statistics and Epidemiology, Technical University, Munich, Germany,
4. Center of Clinical Epidemiology, Hôpital Hôtel-Dieu, Paris, France,
5. Service de Maladies du Sang, CHU Claude Huriez, Lille Cedex, France,
6. Service d'Hematologie, CHU Poitiers, Poitiers, France,
7. WiSP Wissenschaftlicher Service Pharma GmbH, Langenfeld, Germany,
8. Department of Hematology, Centre de Lutte Contre Le Cancer Henri Becquerel, Rouen, France,
9. German CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany,
10. Day Clinic Hematology Oncology Palliative Care, Landshut, Germany,
11. Department of Hematology, Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine, Klinikum Schwabing, Munich, Germany,
12. Department of Internal Medicine III, University of Ulm, Ulm, Germany,
13. Department of Haematology, Hopital de la Pitie-Salpetriere, Paris, France,
14. Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany,
15. Unité de Recherche Clinique, Hôpital Avicenne, Bobigny, France